{"transactions":[{"id":318913,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Corp Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2025-09-11T23:34:04.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":921,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":7864,"derivative":{"underlying":"Common Stock","underlying_shares":921},"source":{"system":"sec-edgar","filing":"0001374988-25-000005","document":"wk-form4_1757633641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000137498825000005/wk-form4_1757633641.xml","form_type":"4"}},{"id":318912,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Corp Controller & CAO"}}],"security":"Common Stock","published_at":"2025-09-11T23:34:04.000Z","date":"2025-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":338,"price":115.25,"value":38954.5,"ownership":{"direct":true},"balance_after":46259,"source":{"system":"sec-edgar","filing":"0001374988-25-000005","document":"wk-form4_1757633641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000137498825000005/wk-form4_1757633641.xml","form_type":"4"}},{"id":318911,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Corp Controller & CAO"}}],"security":"Common Stock","published_at":"2025-09-11T23:34:04.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":921,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":46597,"source":{"system":"sec-edgar","filing":"0001374988-25-000005","document":"wk-form4_1757633641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000137498825000005/wk-form4_1757633641.xml","form_type":"4"}},{"id":321515,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"Interim Corp Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2025-06-11T23:10:19.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":false,"shares":920,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":8785,"derivative":{"underlying":"Common Stock","underlying_shares":920},"source":{"system":"sec-edgar","filing":"0001127602-25-017339","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017339/form4.xml","form_type":"4"}},{"id":321514,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"Interim Corp Controller & CAO"}}],"security":"Common Stock","published_at":"2025-06-11T23:10:19.000Z","date":"2025-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":340,"price":110.09,"value":37430.6,"ownership":{"direct":true},"balance_after":45676,"source":{"system":"sec-edgar","filing":"0001127602-25-017339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017339/form4.xml","form_type":"4"}},{"id":321513,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"Interim Corp Controller & CAO"}}],"security":"Common Stock","published_at":"2025-06-11T23:10:19.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":true,"shares":920,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":46016,"source":{"system":"sec-edgar","filing":"0001127602-25-017339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225017339/form4.xml","form_type":"4"}},{"id":1544495,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-09T16:20:52.000Z","date":"2024-04-05","kind":"other","planned":false,"acquired":false,"shares":13222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was scheduled to vest in full as of June 16, 2024."}],"balance_after":0,"derivative":{"exercise_price":1.34,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":13222},"source":{"system":"sec-edgar","filing":"0001415889-24-010568","document":"form4-04092024_080446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000141588924010568/form4-04092024_080446.xml","form_type":"4"}},{"id":1544494,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-09T16:20:52.000Z","date":"2024-04-05","kind":"other","planned":false,"acquired":false,"shares":12789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.65,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":12789},"source":{"system":"sec-edgar","filing":"0001415889-24-010568","document":"form4-04092024_080446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000141588924010568/form4-04092024_080446.xml","form_type":"4"}},{"id":1544493,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-09T16:20:52.000Z","date":"2024-04-05","kind":"other","planned":false,"acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.96,"expiration_date":"2031-07-10","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001415889-24-010568","document":"form4-04092024_080446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000141588924010568/form4-04092024_080446.xml","form_type":"4"}},{"id":1544492,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-09T16:20:52.000Z","date":"2024-04-05","kind":"other","planned":false,"acquired":false,"shares":31356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.02,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":31356},"source":{"system":"sec-edgar","filing":"0001415889-24-010568","document":"form4-04092024_080446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000141588924010568/form4-04092024_080446.xml","form_type":"4"}},{"id":1849410,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T18:39:46.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":13222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is 100% vested on June 16, 2024."}],"balance_after":13222,"derivative":{"exercise_price":1.34,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":13222},"source":{"system":"sec-edgar","filing":"0001209191-23-038603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123038603/doc4.xml","form_type":"4"}},{"id":354019,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-07T22:47:01.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":1864,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested."}],"balance_after":11060,"derivative":{"underlying":"Common Stock","underlying_shares":1864},"source":{"system":"sec-edgar","filing":"0001127602-23-003825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223003825/form4.xml","form_type":"4"}},{"id":354018,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2023-02-07T22:47:01.000Z","date":"2023-02-06","kind":"tax_withholding","acquired":false,"shares":565,"price":86.36,"value":48793.4,"ownership":{"direct":true},"balance_after":32010,"source":{"system":"sec-edgar","filing":"0001127602-23-003825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223003825/form4.xml","form_type":"4"}},{"id":354017,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2023-02-07T22:47:01.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":1864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":32575,"source":{"system":"sec-edgar","filing":"0001127602-23-003825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223003825/form4.xml","form_type":"4"}},{"id":354524,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2023-01-26T20:37:09.000Z","date":"2023-01-24","kind":"tax_withholding","acquired":false,"shares":1244,"price":84.02,"value":104520.88,"ownership":{"direct":true},"balance_after":30711,"source":{"system":"sec-edgar","filing":"0001127602-23-002284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223002284/form4.xml","form_type":"4"}},{"id":354523,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2023-01-26T20:37:09.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on March 10, 2020. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":31955,"source":{"system":"sec-edgar","filing":"0001127602-23-002284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223002284/form4.xml","form_type":"4"}},{"id":354522,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2023-01-26T20:37:09.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":1784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2021 and March 10, 2022. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":27855,"source":{"system":"sec-edgar","filing":"0001127602-23-002284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223002284/form4.xml","form_type":"4"}},{"id":355943,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-12-13T20:15:22.000Z","date":"2022-12-10","kind":"exercise","acquired":false,"shares":318,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":12924,"derivative":{"underlying":"Common Stock","underlying_shares":318},"source":{"system":"sec-edgar","filing":"0001127602-22-027390","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222027390/form4.xml","form_type":"4"}},{"id":355942,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-12-13T20:15:22.000Z","date":"2022-12-10","kind":"tax_withholding","acquired":false,"shares":149,"price":87.97,"value":13107.53,"ownership":{"direct":true},"balance_after":28502,"source":{"system":"sec-edgar","filing":"0001127602-22-027390","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222027390/form4.xml","form_type":"4"}},{"id":355941,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-12-13T20:15:22.000Z","date":"2022-12-10","kind":"exercise","acquired":true,"shares":318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":28651,"source":{"system":"sec-edgar","filing":"0001127602-22-027390","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222027390/form4.xml","form_type":"4"}},{"id":356721,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-11-10T21:20:47.000Z","date":"2022-11-09","kind":"exercise","acquired":false,"shares":6416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":10694,"derivative":{"exercise_price":63.91,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":6416},"source":{"system":"sec-edgar","filing":"0001127602-22-025292","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222025292/form4.xml","form_type":"4"}},{"id":356720,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-11-10T21:20:47.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":6416,"price":83.5,"value":535736.0,"ownership":{"direct":true},"balance_after":28333,"source":{"system":"sec-edgar","filing":"0001127602-22-025292","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222025292/form4.xml","form_type":"4"}},{"id":356719,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-11-10T21:20:47.000Z","date":"2022-11-09","kind":"exercise","acquired":true,"shares":6416,"price":63.91,"value":410046.56,"ownership":{"direct":true},"balance_after":34749,"source":{"system":"sec-edgar","filing":"0001127602-22-025292","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222025292/form4.xml","form_type":"4"}},{"id":356990,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-11-02T20:57:28.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":16255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a three year vesting schedule. 33.33% vest on the first anniversary of the date of the grant. The balance will vest 8.33% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":72.7,"expiration_date":"2027-08-10","underlying":"Common Stock","underlying_shares":16255},"source":{"system":"sec-edgar","filing":"0001127602-22-024778","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222024778/form4.xml","form_type":"4"}},{"id":356989,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-11-02T20:57:28.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":16255,"price":79.25,"value":1288208.75,"ownership":{"direct":true},"balance_after":28333,"source":{"system":"sec-edgar","filing":"0001127602-22-024778","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222024778/form4.xml","form_type":"4"}},{"id":356988,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-11-02T20:57:28.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":16255,"price":72.7,"value":1181738.5,"ownership":{"direct":true},"balance_after":44588,"source":{"system":"sec-edgar","filing":"0001127602-22-024778","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222024778/form4.xml","form_type":"4"}},{"id":358178,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-09-12T20:03:33.000Z","date":"2022-09-10","kind":"exercise","acquired":false,"shares":318,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13242,"derivative":{"underlying":"Common Stock","underlying_shares":318},"source":{"system":"sec-edgar","filing":"0001127602-22-022289","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222022289/form4.xml","form_type":"4"}},{"id":358177,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-09-12T20:03:33.000Z","date":"2022-09-10","kind":"tax_withholding","acquired":false,"shares":148,"price":65.28,"value":9661.44,"ownership":{"direct":true},"balance_after":28333,"source":{"system":"sec-edgar","filing":"0001127602-22-022289","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222022289/form4.xml","form_type":"4"}},{"id":358176,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-09-12T20:03:33.000Z","date":"2022-09-10","kind":"exercise","acquired":true,"shares":318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":28481,"source":{"system":"sec-edgar","filing":"0001127602-22-022289","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222022289/form4.xml","form_type":"4"}},{"id":358869,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-08-11T21:26:14.000Z","date":"2022-08-10","kind":"exercise","acquired":false,"shares":2479,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":13560,"derivative":{"underlying":"Common Stock","underlying_shares":2479},"source":{"system":"sec-edgar","filing":"0001127602-22-020842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222020842/form4.xml","form_type":"4"}},{"id":358868,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-08-11T21:26:14.000Z","date":"2022-08-10","kind":"tax_withholding","acquired":false,"shares":1066,"price":63.14,"value":67307.24,"ownership":{"direct":true},"balance_after":28163,"source":{"system":"sec-edgar","filing":"0001127602-22-020842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222020842/form4.xml","form_type":"4"}},{"id":358867,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-08-11T21:26:14.000Z","date":"2022-08-10","kind":"exercise","acquired":true,"shares":2479,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":29229,"source":{"system":"sec-edgar","filing":"0001127602-22-020842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222020842/form4.xml","form_type":"4"}},{"id":2227534,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T17:06:56.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":12789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is 100% vested on June 16, 2023."}],"balance_after":12789,"derivative":{"exercise_price":8.65,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":12789},"source":{"system":"sec-edgar","filing":"0001209191-22-037961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919122037961/doc4.xml","form_type":"4"}},{"id":360413,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-06-14T00:06:05.000Z","date":"2022-06-10","kind":"exercise","acquired":false,"shares":317,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":16039,"derivative":{"underlying":"Common Stock","underlying_shares":317},"source":{"system":"sec-edgar","filing":"0001127602-22-017330","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017330/form4.xml","form_type":"4"}},{"id":360412,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-06-14T00:06:05.000Z","date":"2022-06-10","kind":"tax_withholding","acquired":false,"shares":148,"price":60.74,"value":8989.52,"ownership":{"direct":true},"balance_after":26750,"source":{"system":"sec-edgar","filing":"0001127602-22-017330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017330/form4.xml","form_type":"4"}},{"id":360411,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-06-14T00:06:05.000Z","date":"2022-06-10","kind":"exercise","acquired":true,"shares":317,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":26898,"source":{"system":"sec-edgar","filing":"0001127602-22-017330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222017330/form4.xml","form_type":"4"}},{"id":363934,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-03-15T01:30:18.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":5610,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":16356,"derivative":{"underlying":"Common Stock","underlying_shares":5610},"source":{"system":"sec-edgar","filing":"0001127602-22-009211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009211/form4.xml","form_type":"4"}},{"id":363933,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-03-15T01:30:18.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":18850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":18850,"derivative":{"exercise_price":57.92,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":18850},"source":{"system":"sec-edgar","filing":"0001127602-22-009211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009211/form4.xml","form_type":"4"}},{"id":363932,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-03-15T01:30:18.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":1272,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":10746,"derivative":{"underlying":"Common Stock","underlying_shares":1272},"source":{"system":"sec-edgar","filing":"0001127602-22-009211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009211/form4.xml","form_type":"4"}},{"id":363931,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-03-15T01:30:18.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":2025,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested."}],"balance_after":12018,"derivative":{"underlying":"Common Stock","underlying_shares":2025},"source":{"system":"sec-edgar","filing":"0001127602-22-009211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009211/form4.xml","form_type":"4"}},{"id":363930,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-03-15T01:30:18.000Z","date":"2022-03-10","kind":"tax_withholding","acquired":false,"shares":935,"price":57.92,"value":54155.2,"ownership":{"direct":true},"balance_after":26581,"source":{"system":"sec-edgar","filing":"0001127602-22-009211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009211/form4.xml","form_type":"4"}},{"id":363929,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-03-15T01:30:18.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":1272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":27516,"source":{"system":"sec-edgar","filing":"0001127602-22-009211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009211/form4.xml","form_type":"4"}},{"id":363928,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-03-15T01:30:18.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":2025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":26244,"source":{"system":"sec-edgar","filing":"0001127602-22-009211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222009211/form4.xml","form_type":"4"}},{"id":366375,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2022-02-09T01:22:51.000Z","date":"2022-02-06","kind":"exercise","acquired":false,"shares":1864,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":14043,"derivative":{"underlying":"Common Stock","underlying_shares":1864},"source":{"system":"sec-edgar","filing":"0001127602-22-003845","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222003845/form4.xml","form_type":"4"}},{"id":366374,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-02-09T01:22:51.000Z","date":"2022-02-06","kind":"tax_withholding","acquired":false,"shares":520,"price":63.9,"value":33228.0,"ownership":{"direct":true},"balance_after":24219,"source":{"system":"sec-edgar","filing":"0001127602-22-003845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222003845/form4.xml","form_type":"4"}},{"id":366373,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-02-09T01:22:51.000Z","date":"2022-02-06","kind":"exercise","acquired":true,"shares":1864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":24739,"source":{"system":"sec-edgar","filing":"0001127602-22-003845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222003845/form4.xml","form_type":"4"}},{"id":367080,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-01-29T01:47:22.000Z","date":"2022-01-26","kind":"tax_withholding","acquired":false,"shares":394,"price":67.34,"value":26531.96,"ownership":{"direct":true},"balance_after":22875,"source":{"system":"sec-edgar","filing":"0001127602-22-002464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222002464/form4.xml","form_type":"4"}},{"id":367079,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-01-29T01:47:22.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":1157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 6, 2019. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":23269,"source":{"system":"sec-edgar","filing":"0001127602-22-002464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222002464/form4.xml","form_type":"4"}},{"id":367078,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2022-01-29T01:47:22.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":1714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2020, and March 10, 2021. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":22112,"source":{"system":"sec-edgar","filing":"0001127602-22-002464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222002464/form4.xml","form_type":"4"}},{"id":372314,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-08-18T23:32:02.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":3829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":66.36,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":3829},"source":{"system":"sec-edgar","filing":"0001127602-21-023999","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023999/form4.xml","form_type":"4"}},{"id":372313,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-08-18T23:32:02.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":9781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":5869,"derivative":{"exercise_price":68.75,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":9781},"source":{"system":"sec-edgar","filing":"0001127602-21-023999","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023999/form4.xml","form_type":"4"}},{"id":372312,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-08-18T23:32:02.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":13610,"price":72.5,"value":986725.0,"ownership":{"direct":true},"balance_after":20398,"source":{"system":"sec-edgar","filing":"0001127602-21-023999","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023999/form4.xml","form_type":"4"}},{"id":372311,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-08-18T23:32:02.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":3829,"price":66.36,"value":254092.44,"ownership":{"direct":true},"balance_after":34008,"source":{"system":"sec-edgar","filing":"0001127602-21-023999","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023999/form4.xml","form_type":"4"}},{"id":372310,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-08-18T23:32:02.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":9781,"price":68.75,"value":672443.75,"ownership":{"direct":true},"balance_after":30179,"source":{"system":"sec-edgar","filing":"0001127602-21-023999","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023999/form4.xml","form_type":"4"}},{"id":372521,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2021-08-12T19:52:06.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":2480,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":15907,"derivative":{"underlying":"Common Stock","underlying_shares":2480},"source":{"system":"sec-edgar","filing":"0001127602-21-023570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023570/form4.xml","form_type":"4"}},{"id":372520,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-08-12T19:52:06.000Z","date":"2021-08-10","kind":"tax_withholding","acquired":false,"shares":907,"price":69.24,"value":62800.68,"ownership":{"direct":true},"balance_after":20398,"source":{"system":"sec-edgar","filing":"0001127602-21-023570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023570/form4.xml","form_type":"4"}},{"id":372519,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-08-12T19:52:06.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":2480,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":21305,"source":{"system":"sec-edgar","filing":"0001127602-21-023570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221023570/form4.xml","form_type":"4"}},{"id":2634802,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-13T17:12:06.000Z","date":"2021-07-11","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is 100% vested on July 11, 2022."}],"balance_after":11500,"derivative":{"exercise_price":9.96,"expiration_date":"2031-07-10","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-21-046572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919121046572/doc4.xml","form_type":"4"}},{"id":377932,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2021-03-13T00:33:01.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":5085,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":18387,"derivative":{"underlying":"Common Stock","underlying_shares":5085},"source":{"system":"sec-edgar","filing":"0001127602-21-010481","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010481/form4.xml","form_type":"4"}},{"id":377931,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-03-13T00:33:01.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":17110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":17110,"derivative":{"exercise_price":63.91,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":17110},"source":{"system":"sec-edgar","filing":"0001127602-21-010481","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010481/form4.xml","form_type":"4"}},{"id":377930,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2021-03-13T00:33:01.000Z","date":"2021-03-10","kind":"exercise","acquired":false,"shares":2025,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":13302,"derivative":{"underlying":"Common Stock","underlying_shares":2025},"source":{"system":"sec-edgar","filing":"0001127602-21-010481","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010481/form4.xml","form_type":"4"}},{"id":377929,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-03-13T00:33:01.000Z","date":"2021-03-10","kind":"tax_withholding","acquired":false,"shares":609,"price":63.91,"value":38921.19,"ownership":{"direct":true},"balance_after":18825,"source":{"system":"sec-edgar","filing":"0001127602-21-010481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010481/form4.xml","form_type":"4"}},{"id":377928,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-03-13T00:33:01.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":2025,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":19434,"source":{"system":"sec-edgar","filing":"0001127602-21-010481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221010481/form4.xml","form_type":"4"}},{"id":380551,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2021-02-11T22:58:02.000Z","date":"2021-02-10","kind":"exercise","acquired":false,"shares":778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":15327,"derivative":{"underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0001127602-21-005279","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221005279/form4.xml","form_type":"4"}},{"id":380550,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-02-11T22:58:02.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":197,"price":67.29,"value":13256.13,"ownership":{"direct":true},"balance_after":17409,"source":{"system":"sec-edgar","filing":"0001127602-21-005279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221005279/form4.xml","form_type":"4"}},{"id":380549,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-02-11T22:58:02.000Z","date":"2021-02-10","kind":"exercise","acquired":true,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":17606,"source":{"system":"sec-edgar","filing":"0001127602-21-005279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221005279/form4.xml","form_type":"4"}},{"id":380670,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2021-02-10T00:46:43.000Z","date":"2021-02-06","kind":"exercise","acquired":false,"shares":1866,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":16105,"derivative":{"underlying":"Common Stock","underlying_shares":1866},"source":{"system":"sec-edgar","filing":"0001127602-21-004792","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221004792/form4.xml","form_type":"4"}},{"id":380669,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-02-10T00:46:43.000Z","date":"2021-02-06","kind":"tax_withholding","acquired":false,"shares":533,"price":68.46,"value":36489.18,"ownership":{"direct":true},"balance_after":16828,"source":{"system":"sec-edgar","filing":"0001127602-21-004792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221004792/form4.xml","form_type":"4"}},{"id":380668,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-02-10T00:46:43.000Z","date":"2021-02-06","kind":"exercise","acquired":true,"shares":1866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":17361,"source":{"system":"sec-edgar","filing":"0001127602-21-004792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221004792/form4.xml","form_type":"4"}},{"id":381264,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2021-01-29T01:06:27.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":1294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met."}],"balance_after":15495,"source":{"system":"sec-edgar","filing":"0001127602-21-002918","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221002918/form4.xml","form_type":"4"}},{"id":384006,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-11-12T22:34:17.000Z","date":"2020-11-10","kind":"exercise","acquired":false,"shares":657,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":17971,"derivative":{"underlying":"Common Stock","underlying_shares":657},"source":{"system":"sec-edgar","filing":"0001127602-20-028854","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220028854/form4.xml","form_type":"4"}},{"id":384005,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-11-12T22:34:17.000Z","date":"2020-11-10","kind":"exercise","acquired":false,"shares":773,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":18628,"derivative":{"underlying":"Common Stock","underlying_shares":773},"source":{"system":"sec-edgar","filing":"0001127602-20-028854","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220028854/form4.xml","form_type":"4"}},{"id":384004,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-11-12T22:34:17.000Z","date":"2020-11-10","kind":"tax_withholding","acquired":false,"shares":611,"price":60.62,"value":37038.82,"ownership":{"direct":true},"balance_after":14201,"source":{"system":"sec-edgar","filing":"0001127602-20-028854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220028854/form4.xml","form_type":"4"}},{"id":384003,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-11-12T22:34:17.000Z","date":"2020-11-10","kind":"exercise","acquired":true,"shares":657,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":14812,"source":{"system":"sec-edgar","filing":"0001127602-20-028854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220028854/form4.xml","form_type":"4"}},{"id":384002,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-11-12T22:34:17.000Z","date":"2020-11-10","kind":"exercise","acquired":true,"shares":773,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":14155,"source":{"system":"sec-edgar","filing":"0001127602-20-028854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220028854/form4.xml","form_type":"4"}},{"id":387317,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-08-12T18:59:42.000Z","date":"2020-08-10","kind":"exercise","acquired":false,"shares":3345,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":19401,"derivative":{"underlying":"Common Stock","underlying_shares":3345},"source":{"system":"sec-edgar","filing":"0001127602-20-023432","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220023432/form4.xml","form_type":"4"}},{"id":387316,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-08-12T18:59:42.000Z","date":"2020-08-10","kind":"tax_withholding","acquired":false,"shares":1384,"price":68.51,"value":94817.84,"ownership":{"direct":true},"balance_after":13382,"source":{"system":"sec-edgar","filing":"0001127602-20-023432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220023432/form4.xml","form_type":"4"}},{"id":387315,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-08-12T18:59:42.000Z","date":"2020-08-10","kind":"exercise","acquired":true,"shares":3345,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":14766,"source":{"system":"sec-edgar","filing":"0001127602-20-023432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220023432/form4.xml","form_type":"4"}},{"id":391127,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-05-06T22:40:14.000Z","date":"2020-05-04","kind":"exercise","acquired":false,"shares":11486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":3829,"derivative":{"exercise_price":66.36,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":11486},"source":{"system":"sec-edgar","filing":"0001127602-20-015665","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015665/form4.xml","form_type":"4"}},{"id":391126,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-05-06T22:40:14.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":12264,"price":80.0897,"value":982220.0808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $80.07 to $80.14.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":11421,"source":{"system":"sec-edgar","filing":"0001127602-20-015665","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015665/form4.xml","form_type":"4"}},{"id":391125,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-05-06T22:40:14.000Z","date":"2020-05-04","kind":"exercise","acquired":true,"shares":11486,"price":66.36,"value":762210.96,"ownership":{"direct":true},"balance_after":23685,"source":{"system":"sec-edgar","filing":"0001127602-20-015665","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220015665/form4.xml","form_type":"4"}},{"id":393185,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-03-13T00:10:05.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":5180,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":22746,"derivative":{"underlying":"Common Stock","underlying_shares":5180},"source":{"system":"sec-edgar","filing":"0001127602-20-010508","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010508/form4.xml","form_type":"4"}},{"id":393184,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-03-13T00:10:05.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":17630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":17630,"derivative":{"exercise_price":72.34,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":17630},"source":{"system":"sec-edgar","filing":"0001127602-20-010508","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010508/form4.xml","form_type":"4"}},{"id":393183,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-03-13T00:10:05.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":1865,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":17566,"derivative":{"underlying":"Common Stock","underlying_shares":1865},"source":{"system":"sec-edgar","filing":"0001127602-20-010508","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010508/form4.xml","form_type":"4"}},{"id":393182,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-03-13T00:10:05.000Z","date":"2020-03-10","kind":"tax_withholding","acquired":false,"shares":524,"price":72.34,"value":37906.16,"ownership":{"direct":true},"balance_after":12199,"source":{"system":"sec-edgar","filing":"0001127602-20-010508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010508/form4.xml","form_type":"4"}},{"id":393181,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-03-13T00:10:05.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":1865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":12723,"source":{"system":"sec-edgar","filing":"0001127602-20-010508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010508/form4.xml","form_type":"4"}},{"id":393180,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-03-13T00:10:05.000Z","date":"2020-02-15","kind":"grant","acquired":true,"shares":264,"price":53.669,"value":14168.616,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of August 16,\n2019 through February 15, 2020. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on February 15, 2020."}],"balance_after":10858,"source":{"system":"sec-edgar","filing":"0001127602-20-010508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220010508/form4.xml","form_type":"4"}},{"id":395525,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-02-12T19:51:46.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":779,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":19431,"derivative":{"underlying":"Common Stock","underlying_shares":779},"source":{"system":"sec-edgar","filing":"0001127602-20-005053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220005053/form4.xml","form_type":"4"}},{"id":395524,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-02-12T19:51:46.000Z","date":"2020-02-10","kind":"tax_withholding","acquired":false,"shares":219,"price":68.99,"value":15108.81,"ownership":{"direct":true},"balance_after":10594,"source":{"system":"sec-edgar","filing":"0001127602-20-005053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220005053/form4.xml","form_type":"4"}},{"id":395523,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-02-12T19:51:46.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":10813,"source":{"system":"sec-edgar","filing":"0001127602-20-005053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220005053/form4.xml","form_type":"4"}},{"id":395691,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-02-10T19:52:34.000Z","date":"2020-02-06","kind":"exercise","acquired":false,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":20210,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001127602-20-004546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004546/form4.xml","form_type":"4"}},{"id":395690,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Restricted Stock Unit","published_at":"2020-02-10T19:52:34.000Z","date":"2020-02-06","kind":"exercise","acquired":false,"shares":1228,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":20848,"derivative":{"underlying":"Common Stock","underlying_shares":1228},"source":{"system":"sec-edgar","filing":"0001127602-20-004546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004546/form4.xml","form_type":"4"}},{"id":395689,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-02-10T19:52:34.000Z","date":"2020-02-06","kind":"tax_withholding","acquired":false,"shares":658,"price":68.21,"value":44882.18,"ownership":{"direct":true},"balance_after":10034,"source":{"system":"sec-edgar","filing":"0001127602-20-004546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004546/form4.xml","form_type":"4"}},{"id":395688,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-02-10T19:52:34.000Z","date":"2020-02-06","kind":"exercise","acquired":true,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":10692,"source":{"system":"sec-edgar","filing":"0001127602-20-004546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004546/form4.xml","form_type":"4"}},{"id":395687,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15063,"kind":"person","name":"Wilfong Diane E.","position":1,"cik":"0001374988","reported_name":"Wilfong Diane E.","relationship":{"officer":true,"officer_title":"SVP, Controller & CAO"}}],"security":"Common Stock","published_at":"2020-02-10T19:52:34.000Z","date":"2020-02-06","kind":"exercise","acquired":true,"shares":1228,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":10054,"source":{"system":"sec-edgar","filing":"0001127602-20-004546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220004546/form4.xml","form_type":"4"}}]}